Chromatography
Non-invasive Cancer Detection System Uses Sensing Ocean Optics Expertise
Dec 20 2005
Developed by the Bioscience Division of the U.S. Department of Energy, the technology has been licensed to, and further developed by, SpectraPath Technologies. It is hoped that the system will allow physicians to screen patients quickly, providing instant diagnoses, without requiring invasive and time-consuming biopsies for skin, cervical, brain, oesophageal and colorectal cancers.
At the heart of the system is a USB2000 palm sized spectrometer. It is used to analyse the elastic light scattering (ELS) spectrum produced by cellular nuclei. An LS-1 Tungsten Halogen Light Source and single optical fibre probe are used to illuminate the tissue surface. The probe then captures the resulting ELS spectrum. Larger nuclei in cancerous and pre-cancerous cells cause different ELS spectra from normal nuclei.
The CancerScanner? has so far been successfully tested in both animals and humans for a variety of cancer types. It is small, lightweight, and will be economically practical for hospitals, physician offices and patient services centres.
Digital Edition
ILM Guide 2025/26
June 2025
Buyers' Guide Listings- Product Listings by Category- Suppliers Listings (A-Z)Chromatography Articles- Setting the power coefficient and the baseline to linearise the signal of the evaporative ligh...
View all digital editions
Events
Jun 24 2025 Warsaw, Poland
Jun 24 2025 Shanghai, China
Discovery & Development Europe 2025
Jul 01 2025 Basel, Switzerland
Jul 01 2025 Manchester, UK
Jul 08 2025 Johannesburg, South Africa